Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

about

Idiopathic Pulmonary Fibrosis (IPF): An Overview Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience

P2860

Q57170607-D4C16F70-56BB-44BB-8286-E4DFA3EF11A3 Q57811298-28AD5E48-9CFF-43B4-B92F-90783A15174E Q58698965-2B230C97-7CF7-4E6F-A05F-A0D83D84977B

P2860

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Item

http://www.wikidata.org/entity/Q51410548

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@en

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@nl

type

Item

label

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@en

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@nl

prefLabel

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@en

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@nl

P1476

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

@en

P2093

Arne Warth

http://www.w3.org/2001/XMLSchema#string

Claus Peter Heussel

http://www.w3.org/2001/XMLSchema#string

Eva Brunnemer

http://www.w3.org/2001/XMLSchema#string

Felix J F Herth

http://www.w3.org/2001/XMLSchema#string

Julia Hausmanns

http://www.w3.org/2001/XMLSchema#string

Julia Wälscher

http://www.w3.org/2001/XMLSchema#string

Karen Schulze

http://www.w3.org/2001/XMLSchema#string

Marianne Seiter

http://www.w3.org/2001/XMLSchema#string

Michael Kreuter

http://www.w3.org/2001/XMLSchema#string

Svenja Tenenbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis

Update on therapeutic management of idiopathic pulmonary fibrosis

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Acute exacerbations of idiopathic pulmonary fibrosis

P304

301-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000485933

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29490307

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5985741

http://www.w3.org/2001/XMLSchema#string

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

about

P2860

P2860

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932